Allermont Chewable Tablet 4mg (Montelukast Sodium)

Adult dose

Adults and adolescents aged 15 years and older should take 10 mg orally once daily. 10 mg oral dissolving film should be placed on the tongue and allowed to dissolve without water once daily. This medication is taken once daily; for asthma patients, it is recommended to take it in the evening.

Child dose

Children aged 6 to 14 years should chew 5 mg once daily or place it on the tongue and allow it to disintegrate without water. 5 mg dry syrup should be administered orally as 5 mg once daily.

This medication is used for the treatment of asthma and allergic rhinitis and should not be administered to patients who are allergic to it or its components. This medication is not intended for use during acute asthma attacks, so appropriate emergency medication should always be available during such episodes. While you may continue taking this medication if asthma symptoms worsen, do not abruptly stop inhaled corticosteroids or switch to this medicine. In cases of exercise-induced bronchospasm, do not use this medication alone; inhaled beta agonists should be used in conjunction. Patients who have hypersensitivity to aspirin or nonsteroidal anti-inflammatory drugs should avoid these medications while taking this drug. There may be rare, serious side effects such as systemic eosinophilia and vasculitis while taking this drug, so patients should seek medical attention immediately if symptoms such as eosinophilia, skin rash, or pulmonary symptoms worsen. During treatment with this medication, various side effects such as headache, fever, cough, abdominal pain, diarrhea, and rash may occur, and if symptoms persist or worsen, consult healthcare personnel. Use this medication during pregnancy only when necessary, and breastfeeding mothers should be cautious, as this drug may be excreted in breast milk. This medication should not be administered to infants under 6 months of age, as safety and efficacy have not been established. Elderly patients may use this medication, but caution is necessary due to potential differences in age-related responses. In case of overdose, there is no specific antidote, but general symptomatic treatment and clinical monitoring are required. Store this medication out of reach of children, and avoid transferring it to other containers, as it may affect quality. Be sure to take this medication regularly as directed by your doctor, and if symptoms worsen or if you need a short-acting inhaler more frequently, consult your physician. Additionally, if any neuropsychiatric symptoms (e.g., anxiety, agitation, depression, etc.) appear during treatment, notify healthcare personnel immediately. Patients with phenylketonuria should inform healthcare personnel about the phenylalanine content of this medication.

Serious side effects

Urticaria, angioedema, tightness in the chest, difficulty breathing, sweating, paleness, toxic epidermal necrolysis, Stevens-Johnson syndrome, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, shortness of breath or difficulty breathing, asthma attack, abnormal respiratory symptoms accompanied by cough and fever, jaundice (skin or eyes turning yellow), profound lethargy, sudden and severe headache, thunderclap headache, seizures, loss of consciousness

Mild side effects

• Weakness/fatigue
• fever
• abdominal pain
• dyspepsia
• infectious gastroenteritis
• toothache
• dizziness
• headache
• nasal congestion
• cough

This medication is sensitive to light and should be stored in a container that shields it from light, at room temperature between 1°C and 30°C. Proper storage will help maintain the effectiveness of the medication.

Appearance

Pink, biconvex, round chewable tablet

Package unit

28 tablets (7 tablets/PTP × 4)